Further, 12% of all patients with thymoma and myasthenia gravis have CRMP5 antibodies (8), even though CRMP5 expression has not been found in thymus or thymoma either in patients with CRMP5 antibodies or those without (5). The gene discussed is DPYSL5; the disease is thymoma.